| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Dynamique circulatoire et Atherosclerose, Centre Nationale de la Recherche Scientifique, UMR 7131, Paris, France
* To whom correspondence should be addressed. E-mail: pierre.marche{at}brs.ap-hop-paris.fr.
Thrombin is involved in abnormal proliferation of vascular smooth muscle cells (VSMCs) associated with pathogenic vascular remodeling. Thrombin stimulation results in extracellular signal-regulated kinase (ERK 1/2) activation through transactivation of epidermal growth factor receptor (EGFR). Here, using specific antibodies and inhibitors, we investigated thrombin-induced hosphorylation of Src family kinases, nonreceptor proline-rich tyrosine kinase (Pyk2), EGFR and ERK 1/2. Our results show that Src and Pyk2 are involved upstream of EGFR transactivation that is required for ERK 1/2 phosphorylation. The investigation of the role of intracellular calcium concentration ([Ca2+] i ) and calcium mobilization with Ca2+ chelator BAPTA and thapsigargin, respectively, indicates that thrombin- and thapsigargin-induced phosphorylation of EGFR but not ERK 1/2 is dependent on increase in [Ca2+] i . Moreover, only after BAPTA-AM pretreatment, thrombin-induced activation of ERK 1/2 is partially preserved from effects of EGFR and PKC inhibition but not Src family kinase inhibition. These results suggest that BAPTA, by preventing [Ca2+] i elevation, unmask a new pathway of Src family kinase-dependent thrombin-stimulated ERK 1/2 phosphorylation that is independent of EGFR and PKC activation.
This article has been cited by other articles:
|
|
 |
|
  H.-L. Hsieh, W.-H. Tung, C.-Y. Wu, H.-H. Wang, C.-C. Lin, T.-S. Wang, and C.-M. Yang Thrombin Induces EGF Receptor Expression and Cell Proliferation via a PKC({delta})/c-Src-Dependent Pathway in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1594 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. ZHANG, F. LV, L. ZHOU, X. LI, X.-X. WU, and R. M. HOFFMAN Effect of Verapamil on the Expression of EGFR and NM23 in A549 Human Lung Cancer Cells Anticancer Res, January 1, 2009; 29(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zania, M. Papaconstantinou, C. S. Flordellis, M. E. Maragoudakis, and N. E. Tsopanoglou Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1215 - C1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Lee and H. J. Han Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-{kappa}B signal pathways in renal proximal tubule cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F534 - F541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, C.-L. Chou, H. Sun, H. Fujino, Q. M. Chen, and J. W. Regan FP Prostanoid Receptor-Mediated Induction of the Expression of Early Growth Response Factor-1 by Activation of a Ras/Raf/Mitogen-Activated Protein Kinase Signaling Cascade Mol. Pharmacol., January 1, 2008; 73(1): 111 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Dewar, O. S. Gardner, C.-S. Chen, H. S. Earp, J. M. Samet, and L. M. Graves Capacitative Calcium Entry Contributes to the Differential Transactivation of the Epidermal Growth Factor Receptor in Response to Thiazolidinediones Mol. Pharmacol., November 1, 2007; 72(5): 1146 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Rauch, E. Millette, R. D. Kenagy, G. Daum, and A. W. Clowes Thrombin- and Factor Xa-Induced DNA Synthesis Is Mediated by Transactivation of Fibroblast Growth Factor Receptor-1 in Human Vascular Smooth Muscle Cells Circ. Res., February 20, 2004; 94(3): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
